Prostate cancer: Zoladex LA 10.8 mg is indicated in the management of prostate cancer suitable for hormonal manipulation.
Premenopausal Breast cancer: Zoladex LA 10.8mg is indicated in the management of estrogen-receptor-positive breast cancer in premenopausal women.